MDB-99583-13059
3 vaccinations
4 coded responses
33 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 606 / IL
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Registered in v-safe
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-04
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-16
- 2021-04-23
-
2021-04-24
Dose 2 — Pfizer-BioNTech
- 2021-04-24
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesFree text: LightheadednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
- 2021-04-27
-
2021-04-28
Survey response — days 1–6 daily, dose 2MedDRA: Heavy menstrual bleeding, Oligomenorrhoea — Feeling: Good · Site: PainFree text: Menstruating longer and heavier. Period was 6 days lateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-06-05
-
2021-07-24
Survey response — 3 months, dose 2MedDRA: Heavy menstrual bleeding — Feeling: GoodFree text: Heavy periods lasting longer than usual by two or three daysMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-23
Dose 3 — Pfizer-BioNTech
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-04
- 2022-01-22
-
2022-04-23
Survey response — 6 months, dose 3MedDRA: Thyroid mass — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: 4 thyroid nodules- one possibly cancerousMedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech | |
| 3 | 2021-10-23 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Lightheadedness
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Menstruating longer and heavier. Period was 6 days late
Release 9 — 3 months, dose 2
Symptoms: Heavy periods lasting longer than usual by two or three days
Release 11 — 6 months, dose 3
Symptoms: 4 thyroid nodules- one possibly cancerous
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Heavy menstrual bleeding | ✓ | · | ✓ |
| SD | Thyroid mass | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SRO | Oligomenorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release